Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Blood glucose levels are maintained by the balance between glucose uptake by peripheral tissues and glucose secretion by the liver. Gluconeogenesis is strongly stimulated during fasting and is aberrantly activated in diabetes mellitus. Here we show that the transcriptional coactivator PGC-1 is strongly induced in liver in fasting mice and in three mouse models of insulin action deficiency: streptozotocin-induced diabetes, ob/ob genotype and liver insulin-receptor knockout. PGC-1 is induced synergistically in primary liver cultures by cyclic AMP and glucocorticoids. Adenoviral-mediated expression of PGC-1 in hepatocytes in culture or in vivo strongly activates an entire programme of key gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase, leading to increased glucose output. Full transcriptional activation of the PEPCK promoter requires coactivation of the glucocorticoid receptor and the liver-enriched transcription factor HNF-4alpha (hepatic nuclear factor-4alpha) by PGC-1. These results implicate PGC-1 as a key modulator of hepatic gluconeogenesis and as a central target of the insulin-cAMP axis in liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatic gluconeogenesis is promoted by the PKA-mediated phosphorylation of the cAMP response element-binding protein, which in turn upregulates peroxisome proliferator-activated receptor-γ coactivator (PGC)-1.160 Together with the hepatocyte nuclear factor (HNF)-4, PGC-1 induces the transcription of phosphoenolpyruvate carboxykinase,161 which catalyzes the conversion of oxaloacetate into phosphoen”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [161]
In the citing paper
“Previous work has established that repression of either or both co-activators (PGC-1α or PGC-1β) decreases mitochondrial biogenesis and function, elicits cardiomyopathy and impairs de novo glucose production23-25.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [24]
In the citing paper
“In liver PGC-1α is upregulated by fasting and induces a shift in metabolism toward increased glucose output [80].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [80]
In the citing paper
“The metabolic shifts that occur in response to fasting highlight the non-equivalence of PGC-1α function in distinct tissues.”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [80]
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 1×
“We have previously described a coactivator of nuclear receptors and other transcription factors, PGC-1, which has a major role in cellular respiration and adaptive thermogenesis in tissues such as skeletal muscle and brown fa”
BackgroundSelf-citationA Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864 · cited 1×
“We have previously described a coactivator of nuclear receptors and other transcription factors, PGC-1, which has a major role in cellular respiration and adaptive thermogenesis in tissues such as skeletal muscle and brown fa”
BackgroundSelf-citationThe coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · cited 1×
“The liver-specific insulin-receptor knockout (LIRKO) mouse is a unique model of hepato-specific insulin resistance in the liver, and is associated with impaired glucose tolerance and the failure of insulin to suppress hepatic glucose productio”
BackgroundSelf-citationPeroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195 · cited 1×
“This region of PGC-1 has previously been shown to mediate ligand-dependent interactions with the activation function-2 (AF-2) domains of several nuclear receptors, including oestrogen receptor-α (ERα), peroxisome proliferator-activated receptor-α (PPARα) and glucocorticoid recepto”
BackgroundMolecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865 · cited 1×
“Glycogenolysis occurs more rapidly, beginning within 2–3 h after a meal in humans, but gluconeogenesis assumes a much greater importance with prolonged fastin”
BackgroundSelf-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“PGC-1 coactivates HNF-4α and the glucocorticoid receptor The mechanisms underlying the transcriptional activation of the gluconeogenic enzyme PEPCK have been extensively studie”
Background(1997) · Diabetes reviews · Cited by 671
Cited by
Items 801–900 of 1,002
Shakib, K., Norman, J. T., Fine, L. G., Brown, L. R., & Godovac‐Zimmermann, J. (2005) · PROTEOMICS · doi:10.1002/pmic.200401108 · Cited by 44
Lelliott, C. J., Ljungberg, A., Ahnmark, A., William-Olsson, L., Ekroos, K., Elmgren, A., Arnerup, G., Shoulders, C. C., Oscarsson, J., & Lindén, D. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.155739 · Cited by 44
Lonard, D. M., Kumar, R., & O’Malley, B. W. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0276 · Cited by 45
Vetterli, L., & Maechler, P. (2011) · Aging · doi:10.18632/aging.100304 · Cited by 51
“In diabetic animal models, PGC-1α is up-regulated in islets [36] and in the liver [37], resulting in increased hepatic glucose production.”
BackgroundForkhead Box P1 (FOXP1) Transcription Factor Regulates Hepatic Glucose Homeostasis
Zou, Y., Gong, N., Cui, Y., Wang, X., Cui, A., Chen, Q., Jiao, T., Dong, X., Yang, H. Y., Zhang, S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.681627 · Cited by 46
“In mammals, blood glucose levels are maintained within a relatively tight range through regulation of glucose uptake by peripheral tissues and glucose secretion by the liver, protecting the body from hypoglycemia during fasting conditions and from hyperglycemia after a high-carbohydrate meal (1).”
PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway
Liu, Y. X., Cheng, F., Luo, Y., Zhan, Z., Hu, P., Ren, H., Tang, H., & Peng, M. (2017) · BioMed Research International · doi:10.1155/2017/8234507 · Cited by 43
Dechandt, C. R. P., dos Reis, F. H. Z., Teodoro, B. G., Fernandes, A. M. A. P., Eberlin, M. N., Kettelhut, Í. D. C., Curti, C., & Alberici, L. C. (2017) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-017-9725-9 · Cited by 45
p300/CBP as a Key Nutritional Sensor for Hepatic Energy Homeostasis and Liver Fibrosis
Yao, W., Wang, T., & Huang, F. (2018) · BioMed Research International · doi:10.1155/2018/8168791 · Cited by 45
“The elevated expression of gluconeogenesis was the major pathway in increasing hepatic gluconeogenesis [68, 78] and FOXO1 induced accordingly PEPCK1 and G6Pase gene expression [79, 80].”
BackgroundFinamor, I., Bressan, C. A., Torres-Cuevas, I., Rius‐Pérez, S., da Veiga, M. L., da Rocha, M. I. D. U. M., Pavanato, M. A., & Pérez, S. (2021) · Biology · doi:10.3390/biology10020082 · Cited by 45
“Consequently, it prompted us to consider why aspartame occasioned it; therefore, we next decided to investigate the gluconeogenesis pathway in mouse liver since it has been associated with PGC-1 α dysfunction [33,34,58].”
Sjögren, R. J. O., Rizo‐Roca, D., Chibalin, A., Chorell, E., Furrer, R., Katayama, S., Harada, J., Karlsson, H., Handschin, C., Möritz, T., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05481-9 · Cited by 46
PXR activation impairs hepatic glucose metabolism partly via inhibiting the HNF4α–GLUT2 pathway
Liu, P., Jiang, L., Kong, W., Xie, Q., Li, P., Liu, X., Zhang, J., Liu, M., Wang, Z., Zhu, L., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.031 · Cited by 44
Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
Pan, X., & Zhang, Y. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002092 · Cited by 43
“HNF4amay also interact with the co-activator PPARg coactivator 1a (PGC1a) to induce gluconeogenesisduringfasting([97,109])or steroidreceptorcoactivators (SRC-1, -3) to enhance the transcriptional activity of HNF4a,([110,111]) whereas interaction with the co-repressorHes family basichelix-loop-helix transcription facto…”
BackgroundGonzález‐Rodríguez, Á., Clampit, J. E., Escribano, Ó., Benito, M., Rondinone, C. M., & Valverde, Á. M. (2006) · Endocrinology · doi:10.1210/en.2006-0644 · Cited by 48
“Blots were hybridized with cDNA probes for phosphoenolpyruvate carboxykinase (PEPCK) and glucose 6-phosphatase (G6Pase).”
BackgroundInfluentialNiswender, C. M., Willis, B. S., Wallen, A., Sweet, I. R., Jetton, T. L., Thompson, B. R., Wu, C., Lange, A. J., & McKnight, G. S. (2005) · genesis · doi:10.1002/gene.20159 · Cited by 43
“…of peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1), a transcriptional coactivator involved in the initiation of the gluconeogenic program in hepatocytes, via a cAMP-response element binding protein (CREB)-dependent mechanism (Herzig et al., 2001; Yoon et al., 2001).”
BackgroundControl of Hepatic Gluconeogenesis by the Promyelocytic Leukemia Zinc Finger Protein
Chen, S., Qian, J., Shi, X., Gao, T., Liang, T., & Liu, C. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1164 · Cited by 44
“such as GR, hepatocyte nuclear factor 4 (9), and forkhead”
BackgroundFanelli, M., Filippi, E., Sentinelli, F., Romeo, S., Fallarino, M., Buzzetti, R., Leonetti, F., & Baroni, M. G. (2005) · Disease Markers · doi:10.1155/2005/576748 · Cited by 43
Miner, J. N. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01121-8 · Cited by 43
Tunstall, R. J., Mehan, K. A., Hargreaves, M., Spriet, L. L., & Cameron-Smith, D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00473-4 · Cited by 42
“The gene expression and function of PGC-1 and SREBP-1c are important in the transcriptional adaptation to fasting in the liver [44], although evidence for a role of either transcription factor in human skeletal muscle is sparse.”
BackgroundBanzet, S., Koulmann, N., Simler, N., Sanchez, H., Chapot, R., Serrurier, B., Peinnequin, A., & Bigard, X. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00739.2009 · Cited by 42
“Recently, peroxisome proliferator-activated receptor- coactivator-1 (PGC-1 ) has been shown to play a pivotal role in hepatic GNG regulation and PEPCK gene transcription in response to food deprivation (33, 46).”
InfluentialmiR-125a inhibits porcine preadipocytes differentiation by targeting ERRα
Ji, H., Song, C., Li, Y., He, J., Li, Y., Zheng, X., & Yang, G.-S. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2121-4 · Cited by 42
Ιορδανίδου, Π., Aggelidou, E., Demetriades, C., & Hadzopoulou‐Cladaras, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501221200 · Cited by 47
Hallenborg, P., Fjære, E., Liaset, B., Petersen, R. K., Murano, I., Sonne, S. B., Falkerslev, M., Winther, S., Jensen, B. A. H., Ma, T., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00119.2015 · Cited by 42
“PPARGC1a is also important for activation of gluconeogenesis in the liver (27, 65).”
BackgroundHepatic TET3 contributes to type-2 diabetes by inducing the HNF4α fetal isoform
Li, D., Cao, T., Sun, X., Jin, S., Xie, D., Huang, X., Yang, X., Carmichael, G., Taylor, H. S., Diano, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14185-z · Cited by 42
Glucose metabolism in Cushing's syndrome
Sharma, A. R., & Vella, A. V. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000537 · Cited by 44
“This results in activation of hepatic gluconeogenesis by increased transcription of key regulatory enzymes [phosphoenolpyruvate [32] and glucose-6phosphatase (G6P) [33]].”
BackgroundPlacensin is a glucogenic hormone secreted by human placenta
Yu, Y., He, J. H., Hu, L., Jiang, L., Fang, L., Yao, G., Wang, S., Yang, Q., Guo, Y., Liu, L., et al. (2020) · EMBO Reports · doi:10.15252/embr.201949530 · Cited by 43
“Aliquots (10 l l) were dispensed on 48-well plate in 200 l l glucose production buffer consisting of glucose-free DMEM (pH 7.4 without phenol red, supplemented with 20 mM sodium lactate, and 2 mM sodium pyruvate) [56] with or without placensin or glucagon.”
InfluentialHow DNA methylation affects the Warburg effect
Zhu, X., Xuan, Z., Chen, J., Li, Z., Zheng, S., & Song, P. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45420 · Cited by 43
“Moreover, gluconeogenesis, the reverse pathway of glycolysis, requires much more energy than glycolysis since it must overcome the three-step irreversible glycolysis reaction [110,111], which is not efficient for smart tumor cells.”
BackgroundGlucagon and Cyclic AMP: Time to Turn the Page?
L. Rodgers, R. (2012) · Current Diabetes Reviews · doi:10.2174/157339912802083540 · Cited by 42
Multiple Binding Modes between HNF4α and the LXXLL Motifs of PGC-1α Lead to Full Activation
Rha, G. B., Wu, G., Shoelson, S. E., & Chi, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.052506 · Cited by 46
Bechtold, D. A. (2008) · Journal of Genetics · doi:10.1007/s12041-008-0067-6 · Cited by 44
Role of hepatic STAT3 in the regulation of lipid metabolism.
Kinoshita, S., Ogawa, W., Okamoto, Y., Takashima, M., Inoue, H., Matsuki, Y., Watanabe, E., Hiramatsu, R., & Kasuga, M. (2008) · PubMed · doi:10.24546/81000870 · Cited by 43
Mosaic analysis of insulin receptor function
Kitamura, T., Kitamura, Y., Nakae, J., Giordano, A., Cinti, S., Kahn, C. R., Efstratiadis, A., & Accili, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci17810 · Cited by 43
“Pgc1α cooperates with Foxo1 to increase Pck1 and G6pc transcription (7), and the observed increase is likely to represent a compensatory response to increase gluconeogenesis, as observed with prolonged fasting (28).”
BackgroundSelf-citationCoregulator Interactions with the Thyroid Hormone Receptor
Moore, J. M. R., & Guy, R. K. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r500001-mcp200 · Cited by 41
Wang, D. Q. ‐., Portincasa, P., & Neuschwander‐Tetri, B. A. (2013) · Comprehensive physiology · doi:10.1002/cphy.c130001 · Cited by 46
Cell-Type Specific Expression of a Dominant Negative PKA Mutation in Mice
Willis, B. S., Niswender, C. M., Su, T., Amieux, P. S., & McKnight, G. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018772 · Cited by 42
“CREB has also been shown to induce the transcriptional coactivator PGC-1a in the liver [40], which regulates the expression of several gluconeogenic enzymes including PEPCK and G6Pase [30].”
BackgroundChen, Z., Norris, J. Y., & Finck, B. N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141598 · Cited by 44
IHG-1 Promotes Mitochondrial Biogenesis by Stabilizing PGC-1α
Hickey, F. B., Corcoran, J. B., Docherty, N. G., Griffin, B., Bhreathnach, Ú., Furlong, F. M., Martin, F., Godson, C., & Murphy, M. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111154 · Cited by 43
Anti-diabetic activity of peony seed oil, a new resource food in STZ-induced diabetic mice
Su, J., Wang, H., Ma, C., Lou, Z., Liu, C., Rahman, M. R. T., Gao, C., & Nie, R. (2015) · Food & Function · doi:10.1039/c5fo00507h · Cited by 41
Zhang, X., Lv, Q., Jia, S., Chen, Y., Sun, C., Li, X., & Chen, K. (2016) · Food & Function · doi:10.1039/c6fo00397d · Cited by 42
Xu, J., Li, L., Wang, Y. Q., Li, Y., Shan, M., Sun, S., Yu, Y. W., & Wang, B. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m077016 · Cited by 42
“PPAR coactivator-1 (PGC1) activation, which is required for fasting induction (29), was also significantly increased in MT mice compared to WT mice (by 80%) (Fig.”
BackgroundMa, F., Liu, J., Zhou, T., Lei, M., Chen, J., Wang, X., Zhang, Y., Shen, X., & Hu, L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.04.028 · Cited by 41
Goyal, N., Tiwary, S., Kesharwani, D., & Datta, M. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1718-6 · Cited by 43
Epigenetics and In Utero Acquired Predisposition to Metabolic Disease
Deodati, A., Inzaghi, E., & Cianfarani, S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01270 · Cited by 43
“Mice with deletion of this liver-specific miRNAs developed hepatic steatosis, inflammation, and hepatocellular carcinoma (Wen and Friedman, 2012). miRNAs 146b, 143, 34a, and 23a have been found upregulated in NAFLD (Tian et al., 2013).”
BackgroundInfluentialZhan, K., Yang, T., Chen, Y., Jiang, M., & Zhao, G. (2020) · Journal of Dairy Science · doi:10.3168/jds.2019-17309 · Cited by 41
The Role of ARID5B in Acute Lymphoblastic Leukemia and Beyond
Wang, P., Deng, Y., Yan, X., Zhu, J., Yin, Y., Shu, Y., Bai, D., Zhang, S., Xu, H., & Lu, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00598 · Cited by 43
Walter, I. J., & Seebacher, F. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00505.2007 · Cited by 44
“It is known that glucagon and catecholamines activate PGC-1 gene expression in hepatocytes via cAMP and cAMP response element binding protein (CREB) signaling to regulate gluconeogenic gene expression (20, 65).”
Misra, J., Kim, D.-K., Choi, W., Koo, S., Lee, C.-H., Back, S.-H., Kaufman, R. J., & Choi, H.-S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt429 · Cited by 43
“PGC-1a, a member of a small family of coactivators, was identified using yeast two-hybrid assays for peroxisome proliferator-activated receptor g (PPARg)-interacting proteins (23) and is implicated in mitochondrial metabolism, thermogenesis, mitochondrial biogenesis, adipocyte differentiation, gluconeogenesis and gluc…”
MethodStaiger, H., Staiger, K., Haas, C., Weisser, M., Machicao, F. E., & Häring, H.-U. (2005) · Diabetologia · doi:10.1007/s00125-005-1895-z · Cited by 48
“These divergent results might reflect tissue-specific regulation of the genes encoding the two isoforms, as has already been shown in vivo: in type 2 diabetic states, PPARGC1A expression is decreased in skeletal muscle [2, 3] and increased in liver [10].”
ResultMartino, M. U. D., Alesci, S., Chrousos, G. P., & Kino, T. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.006 · Cited by 44
Hepatocyte nuclear factor-4α is a central transactivator of the mouse Ntcp gene
Geier, A., Martin, I. V., Dietrich, C. G., Balasubramaniyan, N., Strauch, S., Suchy, F. J., Gartung, C., Trautwein, C., & Ananthanarayanan, M. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00012.2008 · Cited by 45
Regulation of fibroblast growth factor 15/19 and 21 on metabolism: in the fed or fasted state
Guan, D., Zhao, L., Chen, D., Yu, B., & Yu, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0821-0 · Cited by 42
“PGC-lα as a transcriptional coactivator regulating gluconeogenic gene is increased after FGF21 treatment [62].”
BackgroundRibosomal transcription is regulated by PGC-1alpha and disturbed in Huntington’s disease
Jesse, S., Bayer, H., Alupei, M. C., Zügel, M., Mulaw, M. A., Tuorto, F., Malmsheimer, S., Singh, K., Steinacker, J. M., Schümann, U., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09148-7 · Cited by 41
Wang, C., Le, Y., Lu, D., Zhao, M., Dou, X., & Zhang, Q. (2019) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.121732 · Cited by 41
Acetylation in Nuclear Receptor Signaling and the Role of Sirtuins
Wang, C., Powell, M. J., Popov, V. M., & Pestell, R. G. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0379 · Cited by 42
“coneogenic pathway in fasting and diabetic states through interaction with several transcription factors (31, 32).”
BackgroundCarrière, V., Vidal, R., Lazou, K., Lacasa, M., Delers, F., Ribeiro, A., Rousset, M., Chambaz, J., & Lacorte, J. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408002200 · Cited by 42
The BACE1 product sAPPβ induces ER stress and inflammation and impairs insulin signaling
Botteri, G., Salvadó, L., Gumà, A., Lee Hamilton, D., Meakin, P. J., Montagut, G., Ashford, M. L. J., Ceperuelo-Mallafré, V., Fernández-Veledo, S., Vendrell, J., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.005 · Cited by 39
Hepatic gluconeogenesis and regulatory mechanisms in lactating ruminants: A literature review
Wang, G., Zhu, Y., Feng, D., Yao, J., Cao, Y., & Deng, L. (2024) · Animal Research and One Health · doi:10.1002/aro2.80 · Cited by 39
“With regard to the genes involved in the conversion of pyruvate to glucose, the transcription factor PGC ‐ 1 α has been found to bind to the promoters of FBP and PCK and, thereby, promote the expression of these two genes [60, 61].”
Rulcová, A., Krausová, L., Smutný, T., Vrzal, R., Dvořák, Z., Jover, R., & Pávek, P. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71491-9 · Cited by 44
“USA) [35].”
Tikka, A., Soronen, J., Laurila, P.-P., Metso, J., Ehnholm, C., & Jauhiainen, M. (2014) · Bioscience Reports · doi:10.1042/bsr20140115 · Cited by 39
Nutrigenomics: a case study in the measurement of insect response to nutritional quality
Coudron, T. A., Yocum, G. D., & Brandt, S. L. (2006) · Entomologia Experimentalis et Applicata · doi:10.1111/j.1570-8703.2006.00461.x · Cited by 41
“…1999), a forkhead/winged helix factor FOXC2 (Cederberg et al., 2001), and a transcriptional coactivator PCG-1, which regulates gluconeogenesis (Herzig et al., 2001; Yoon et al., 2001), as well as hormones such as leptin, which controls fat homeostasis and feeding behavior (Friedman & Halaas, 1998).”
BackgroundDkhar, B., Khongsti, K., Thabah, D., Syiem, D., Satyamoorthy, K., & Das, B. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26356 · Cited by 39
KLF10 transcription factor regulates hepatic glucose metabolism in mice
Yang, X., Chen, Q., Sun, L., Zhang, H., Yao, L., Cui, X., Gao, Y., Fang, F., & Chang, Y. (2017) · Diabetologia · doi:10.1007/s00125-017-4412-2 · Cited by 39
“Hepatic expression of PGC-1α is elevated in type 1 and type 2 diabetes mellitus [1, 5, 6].”
BackgroundInfluentialZhu, M. J., Kang, Y., Xue, Y., Liang, X., García, M. P. G., Rodgers, D. B., Kagel, D. R., & Du, . (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.10.012 · Cited by 39
The KLF14 transcription factor regulates hepatic gluconeogenesis in mice
Wang, L., Tong, X., Gu, F., Zhang, L., Chen, W., Cheng, X., Xie, L., Chang, Y., & Zhang, H. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000184 · Cited by 41
“PGC-1 transactivates gluconeogenic gene expression by coactivating a variety of transcription factors, including hepatic nuclear factor-4 (HNF4 ), glucocorticoid receptor, forkhead box O1 (FOXO1), and cAMP-responsive element–binding protein (22).”
BackgroundInfluentialPGC-1α regulates alanine metabolism in muscle cells
Hatazawa, Y., Qian, K., Gong, D., & Kamei, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190904 · Cited by 40
“Moreover, PGC-1 α promotes gluconeogenesis in the liver, during fasting, by increasing phosphoenolpyruvate carbox-ykinase (PEPCK) and glucose 6-phosphatase (G6Pase) [9].”
The journey towards physiology and pathology: Tracing the path of neuregulin 4
Chen, M., Zhu, J., Luo, H., Mu, W., & Guo, L. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.03.021 · Cited by 41
“Peroxisome proliferator-activated receptor-g coactivator-1a (PGC-1a) is a crucial transcriptional coactivator that can stimulate PEPCK and G6Pase expression under the fasting state.(72) Hepatic Nrg4 KD in db/ db mice improved pyruvate tolerance, with down-regulation of PEPCK, G6Pase, and PGC-1a.”
Staudinger, J. L., & Lichti-Kaiser, K. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700098c · Cited by 41
The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance
Shlomai, A., Rechtman, M. M., Burdelova, E. O., Zilberberg, A., Hoffman, S., Solar, I., Fishman, S., Halpern, Z., & Sklan, E. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.021 · Cited by 41
“initiate gluconeogenesis through coactivation of key gluconeogenic enzymes [15, 18, 25].”
BackgroundMethodInfluentialEzrokhi, M., Luo, S., Trubitsyna, Y., & Cincotta, A. H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-104 · Cited by 42
“Such increased fatty acid oxidation also induces an increase in mitochondrial tricarboxylic acid cycle activity (though inadequate for the supply of fatty acids), increased gluconeogenic precursor generation, and subsequent respiratory dysfunction leading to increased generation of ROS [4,8-10,50-55,57] that also stim…”
InfluentialMisra, J., Kim, D., Jung, Y. S., Kim, H. B., Kim, Y., Yoo, E.-K., Kim, B. G., Kim, S., Lee, I., Harris, R. A., et al. (2016) · Diabetes · doi:10.2337/db15-1523 · Cited by 39
“Fasting induces hepatic PGC-1a expression that directly interacts with transcription factors, including hepatocyte nuclear factor 4a, FOXO1, and glucocorticoid receptor, to increase the expression of gluconeogenic genes (21,22).”
Backgroundde Souza, C. T., ARAUJO, E. P. D., Prada, P. O., Saad, M. J. A., Boschero, A. C., & Velloso, L. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1866-4 · Cited by 49
“C HNF-4α levels and restoration of AMPK [Thr172]-phosphorylation and ACC [Ser79]-phosphorylation to levels similar to those observed in SW/Uni/C mice (Fig.”
BackgroundInfluentialPrieur, X., Schaap, F. G., Coste, H., & Rodríguez, J. C. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0048 · Cited by 43
“Additionally, because the hepatic expression of HNF-4 itself is induced after fasting and PGC-1 abundance is increased in fasting and diabetes (26, 30), it will be of great interest to examine the levels of human apoAV expression in these states.”
InfluentialHNF4α isoforms: the fraternal twin master regulators of liver function
Radi, S. H., Vemuri, K., Martinez-Lomeli, J., & Sladek, F. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1226173 · Cited by 41
“While PGC1a was shown some time ago to be required for HNF4a activation of Pck1 and G6pc in the fasted liver, a specific HNF4a isoform was not identified at that time (106, 107).”
BackgroundA postnatal molecular switch drives activity-dependent maturation of parvalbumin interneurons
Moissidis, M., Abbasova, L., Selten, M. M., Alis, R., Bernard, C., Domínguez-Canterla, Y., Oozeer, F., Qin, S., Kelly, A., Mòdol, L., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.029 · Cited by 43
11β-HSD1, Inflammation, Metabolic Disease and Age-related Cognitive (dys)Function
Chapman, K. E., & Seckl, J. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9504-9 · Cited by 47
“Whilst receptor density is a major determinant of glucocorticoid sensitivity [2–4] and cell-specific factors modulate target gene specificity [5, 6], the principal determinant of glucocorticoid action is the level of the ligand, inside the cell.”
BackgroundKiràly, M. A., Campbell, J. E., Park, E., Bates, H. E., Yue, J. T. Y., Rao, V., Matthews, S. G., Bikopoulos, G. J., Rozakis-Adcock, M., Giacca, A., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90575.2008 · Cited by 42
“PGC-1 has been shown to play a pivotal role in hepatic gluconeogenic regulation and PEPCK gene transcription (88).”
BackgroundYao, W., Cai, H., Li, X., Li, T., Hu, L., & Peng, T. (2014) · Journal of Virology · doi:10.1128/jvi.01202-14 · Cited by 39
“Phosphoenolpyruvate carboxykinase (PEPCK), another rate-limiting enzyme for hepatic gluconeogenesis, is also transcriptionally regulated by PGC-1 (6, 7).”
BackgroundHeld-Hoelker, E., Klein, S. L., Rings, F., Salilew‐Wondim, D., Saeed‐Zidane, M., Neuhoff, C., Tesfaye, D., Schellander, K., & Hoelker, M. (2017) · Theriogenology · doi:10.1016/j.theriogenology.2017.03.014 · Cited by 47
Blanco, A. M., Bertucci, J. I., Hatef, A., & Unniappan, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-67535-z · Cited by 40
Glucose Metabolism in Burns—What Happens?
Bădoiu, S. C., Miricescu, D., Stănescu-Spînu, I.-I., Totan, A., Badoiu, S. E., Costagliola, M., & Greabu, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105159 · Cited by 38
Chambers, K. T., Chen, Z., Lai, L., Leone, T. C., Towle, H. C., Kralli, A., Crawford, P. A., & Finck, B. N. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.05.001 · Cited by 36
“The increased hepatic glucose output after PGC-1α overexpression involved marked activation of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase [8,10].”
BackgroundMyles, S., Hradetzky, E., Engelken, J., Lao, Ó., Nürnberg, P., Trent, R. J., Wang, X., Kayser, M., & Stoneking, M. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201793 · Cited by 43
Reduced gluconeogenesis and lactate clearance in Huntington's disease
Josefsen, K. E., Nielsen, S. M. B., Campos, A., Seifert, T., Hasholt, L., Nielsen, J. E., Nørremølle, A., Skotte, N. H., Secher, N. H., & Quistorff, B. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.009 · Cited by 39
Genetic models of PGC-1 and glucose metabolism and homeostasis
Rowe, G. C., & Arany, Z. P. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9273-5 · Cited by 43
“Early in vivo experiments, using primarily adenoviral delivery to the liver of PGC-1α or si-PGC-1α, showed that PGC-1α activates gluconeogenesis by inducing the expression of gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose 6-phosphatase (G-6Pase) [6, 57]).”
BackgroundCan targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review
Pulla, V. K., Battu, M. B., Alvala, M., Sriram, D., & Yogeeswari, P. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.703656 · Cited by 40
Li, L., Zhang, P., Bao, Z., Wang, T., Liu, S., & Huang, F. (2016) · Scientific Reports · doi:10.1038/srep24156 · Cited by 42
Tavares, C. D. J., Sharabi, K., Dominy, J. E., Lee, Y., Isasa, M., Orozco, J. M., Jedrychowski, M. P., Kamenecka, T. M., Griffin, P. R., Gygi, S. P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.706200 · Cited by 42
“Hepatic gluconeogenesis is induced upon fasting and is extensively controlled by PGC-1 (22).”
BackgroundSelf-citationPGC-1?? Genotype Modifies the Association of Volitional Energy Expenditure with &OV0312;O2max
FRANKS, P. W., BARROSO, I., LUAN, J., EKELUND, U., CROWLEY, V. E. F., BRAGE, S., SANDHU, M. S., JAKES, R. W., S. MIDDELBERG, R. P., HARDING, A.-H., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000099109.73351.81 · Cited by 38
Neurocircuits integrating hormone and nutrient signaling in control of glucose metabolism
Rother, E., Könner, A. C., & Brüning, J. C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00685.2007 · Cited by 40
Current In Vitro High Throughput Screening Approaches to Assess Nuclear Receptor Activation
Raucy, J. L., & Lasker, J. M. (2010) · Current Drug Metabolism · doi:10.2174/138920010794328896 · Cited by 39
Fan, Y., Guo, Y., Hamblin, M., Chang, L., Zhang, J., & Chen, Y. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.232918 · Cited by 42
Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls
Weihrauch, M., & Handschin, C. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.10.006 · Cited by 43
“T2DM is a chronic metabolic disorder characterized by insulin resistance, hyperglycemia and insulin deficiency.”
BackgroundInfluentialH19 lncRNA alters methylation and expression of Hnf4α in the liver of metformin-exposed fetuses
Deng, J., Mueller, M., Geng, T., Shen, Y., Liu, Y., Hou, P., Ramillapalli, R., Taylor, H. S., Paidas, M. J., & Huang, Y. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.392 · Cited by 37
“G6pc, thereby activating transcription.(10,13) As hepatic gluconeogenesis normally does not occur at a considerable level until after birth, the apparently premature activation of gluconeogenesis program may contribute to the adverse consequences on glucose metabolism in adulthood.”
BackgroundResultInfluentialRole of ketone signaling in the hepatic response to fasting
Geisler, C. E., Ghimire, S., Bogan, R. L., & Renquist, B. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00415.2017 · Cited by 39
Banerjee, S., Ghoshal, S., Stevens, J. R., McCommis, K. S., Gao, S., Castro‐Sepúlveda, M., Mizgier, M. L., Clemence, G., Kumar, K. G., Galgani, J. E., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014381 · Cited by 38
“The transcriptional co-activator peroxisome proliferator–activated receptor g co-activator 1-a (PGC1A) has a critical role in the liver response to fasting, promoting gluconeogenesis and lipid catabolism (60, 61).”
BackgroundChambers, K. T., Chen, Z., Crawford, P. A., Fu, X., Burgess, S. C., Lai, L., Leone, T. C., Kelly, D. P., & Finck, B. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052645 · Cited by 42
“FOXO1, while PGC-1b can neither coactivate these transcription factors nor regulate the expression of gluconeogenic genes [13,14].”
BackgroundEffect of Biotin Treatment on Hepatic Gene Expression in Streptozotocin-Induced Diabetic Rats
Sugita, Y., Shirakawa, H., Sugimoto, R., Furukawa, Y., & Komai, M. (2008) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.70781 · Cited by 37
Tff3, as a Novel Peptide, Regulates Hepatic Glucose Metabolism
Xue, Y., Shen, L., Cui, Y., Zhang, H., Chen, Q., Cui, A., Fang, F., & Chang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075240 · Cited by 37
“PGC-1α gene expression via CREB/TORC pathway [9,31,32].”
PGC-1α Inhibits Oleic Acid Induced Proliferation and Migration of Rat Vascular Smooth Muscle Cells
Zhang, Y., Liu, C., Zhu, L., Jiang, X., Chen, X., Qi, X., Liang, X., Jin, S., Zhang, P., Li, Q., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001137 · Cited by 39
“switching in muscle [21], of gluconeogenesis in liver [22], and of insulin secretion in islets [23].”
BackgroundJu, Y., Mizutani, T., Imamichi, Y., Yazawa, T., Matsumura, T., Kawabe, S., Kanno, M., Umezawa, A., Kangawa, K., & Miyamoto, K. (2012) · Endocrinology · doi:10.1210/en.2012-1334 · Cited by 37
“It regulates adaptive thermogenesis in brown adipose tissues (20), fiber type switching in skeletal muscle (21), -oxidation of fatty acids (22), and gluconeogenesis (23, 24) in the liver.”
BackgroundHu, R., Yan, H., Fei, X., Liu, H., & Wu, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-00925-y · Cited by 37
Metadata
- Authors
- Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., Newgard, C. B., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- The University of Texas Southwestern Medical Center (US)
- Vanderbilt University (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2001-09
- Volume
- 413
- Issue
- 6852
- Pages
- 131-138
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1523158326
- Cited by
- 1,821
- References
- 33
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 24 · 2023: 48 · 2022: 48 · 2021: 68 · 2020: 63 · 2019: 74 · 2018: 84 · 2017: 67 · 2016: 78 · 2015: 95 · 2014: 75 · 2013: 98 · 2012: 104
- FWCI
- 23.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PGC-1, hepatic gluconeogenesis, transcriptional coactivator, fasting, insulin resistance, diabetes mellitus, phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, glucocorticoid receptor, HNF4α, cyclic AMP, ob/ob mice, streptozotocin-induced diabetes
- MeSH terms
- Cyclic AMP, Animals, Blood Glucose, Cell Line, Diabetes Mellitus, Experimental, DNA-Binding Proteins, Fasting, Gluconeogenesis, Hormones, Insulin, Liver, Male, Obesity, Phosphoenolpyruvate Carboxykinase (GTP), Phosphoproteins, Receptors, Glucocorticoid, Receptor, Insulin, RNA, Messenger, Transcription Factors, Tumor Cells, Cultured, 3T3 Cells, Rats, Wistar, Mice, Knockout, Response Elements, Amino Acid Motifs, Mice, Rats, Hepatocyte Nuclear Factor 4, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.